Entourage Health Announces Results of 2023 Annual General Meeting of Shareholders

TORONTO, June 14, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders (“AGM”) held virtually in Toronto, Ontario on June 14, 2023. 

All director nominees, as listed in the Management Proxy Circular dated May 8, 2023, were elected as directors of the Company, including George Scorsis, Gail Paech, Bruce Croxon, Luciano Cacioppo and Jason Alexander. With a combined average shareholder approval rating of 98%, all elected directors will serve on the Company’s board of directors (the “Board”) until the next AGM or until their successors are elected or appointed.

Additionally, the Company’s shareholders approved and re-appointed MNP LLP as Entourage’s auditor to hold office until the next annual meeting of shareholders or until its successor is duly appointed.

"Over the past year, Entourage has experienced an extraordinary transformation as we stabilized our business practices to align with the shifting cannabis landscape,” stated George Scorsis, Executive Chair and CEO of Entourage. “As we work towards fortifying our financial stability by tackling our debt position and optimizing our capital structure, we sincerely thank our directors for their invaluable contributions and support. Additionally, I want to thank our employees, partners and our shareholders for their unwavering trust and commitment to our success.”

About Entourage Health Corp.

Entourage Health Corp. is the publicly traded parent Company of Entourage Brands Corp., a licence holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a fully licensed 26,000 sq. ft. Aylmer, ON processing facility. With its Starseed Medicinal medical-centric brand, Entourage has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups complements Entourage’s direct sales to medical patients. With the launch of Syndicate, Entourage now hosts another unique medical marketplace that offers patients a collective of Canadian micro-cultivators’ products, along with Entourage’s family of brands. Entourage’s elite adult-use product portfolio includes Color Cannabis and Saturday Cannabis – sold across eight provincial distribution agencies. It is the exclusive Canadian producer and distributor of award-winning U.S.-based wellness brand Mary’s Medicinals sold in both medical and adult-use channels. Under a collaboration with The Boston Beer Company subsidiary, Entourage is also the exclusive distributor of cannabis-infused beverages ‘TeaPot’ in Canada, which launched in summer 2022, starting in select provinces. In addition, Entourage also entered into an exclusive agreement with Irwin Naturals, a renowned nutraceutical and herbal supplement formulator of popular branded wellness products sold across North America. The new line of CBD soft gels is now available on Starseed’s medical platform.